Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Remote control of multiple cell functions through multi-stimuli-responsive nanoparticle assemblies

Project description

Remote control of cells for the future of medicine

Imagine being able to activate, silence, or redirect cells inside your body at the touch of a button, just as easily as tuning a radio. The ERC-funded CELL-NANO-REMOTE project aims to make this a reality. Drawing from fields such as optogenetics and magnetogenetics, the project seeks to achieve remote control over multiple cell functions at once. Specifically, it is combining smart, stimuli-responsive nanoparticles with advanced genetic engineering to create cells that respond to light, magnetic fields, or ultrasound in specific ways. Researchers will use these signals to guide cells to perform complex tasks in real time. This technology could transform immunotherapy, regenerative medicine, and biotechnology.

Objective

CELL-NANO-REMOTE aims to achieve flexible, remote control over therapeutic cell behaviour. In previous work in optogenetics and magnetogenetics, only partial remote cell control has been attained using light or magnetic fields as triggers. Furthermore, these approaches are generally limited to single cell responses, typically influencing one particular gene, receptor, or ion channel. In contrast, CELL-NANO-REMOTE seeks to obtain independent control over various cell functions without cross-activation upon application of external stimuli (light, magnetic fields or ultrasound).

To surpass the limitations of current strategies and achieve the ambitious goal of the project, CELL-NANO-REMOTE combines various stimuli-responsive nanoparticles (NPs) and genetic engineering as ex vivo modification tools of the target cells. To ensure uniform and simultaneous uptake of all the different NPs by cells, they will be assembled into multi-NP assemblies. These multi-NP assemblies will be characterized by nano flow cytometry, a novel technique which enables optimization of assembly conditions to ensure the desired ratio of each component. In response to the application of external stimuli, the NPs will release different cargos inside the engineered cells, providing control over various cell functions. To demonstrate the potential of this approach to improve cell therapies, the project will unfold in two stages: a proof-of-concept stage using a model cell line followed by a second stage showcasing two case studies, in immunology and in regenerative medicine.

The CELL-NANO-REMOTE approach will offer flexible, real-time command of cell behaviour, allowing for adaptable and dynamic control of cell responses. This remote-control system could revolutionize how we manipulate therapeutic cells, offering significant advancements for a wide range of pathologies. Furthermore, this strategy will have applications not only in cell therapy, but also in biotechnology more broadly.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD
Net EU contribution
€ 1 740 080,00
Address
CALLE SEVERO OCHOA 35, PARQUE TECNOLOGICO DE ANDALUCIA
29590 MALAGA
Spain
Region
Sur Andalucía Málaga
Activity type
Research Organisations
Links
Total cost
€ 1 740 080,00

Beneficiaries (1)